Ac-SDKP vs FGF2

Head-to-head comparison of Ac-SDKP (N-Acetyl-Seryl-Aspartyl-Lysyl-Proline) and FGF2 (Recombinant Human Fibroblast Growth Factor 2) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyAc-SDKPFGF2
CategoryRecovery & HealingRecovery & Healing
Full NameN-Acetyl-Seryl-Aspartyl-Lysyl-ProlineRecombinant Human Fibroblast Growth Factor 2
Molecular Weight432.4 Da17.2 kDa
Half-Lifeminutesminutes to <1 hour local
Amino Acids4155
Typical Dose10–100 µg/kg/day in pre-clinical studies1–10 µg/cm²/day
RouteSubcutaneousTopical
Purity≥98%≥98%
Studies Count1801200
Research StatusPre-clinicalClinical

Ac-SDKP Benefits

  • anti-inflammatory tissue remodeling
  • fibroblast modulation
  • microvascular protection
  • faster regenerative signaling

FGF2 Benefits

  • angiogenesis
  • fibroblast proliferation
  • granulation tissue formation
  • accelerated re-epithelialization

Ac-SDKP Dosing

Research-only systemic microdoses|short daily dosing in animal models|route varies by study

FGF2 Dosing

Topical spray/gel daily|intralesional microdoses in studies|short cycles during active repair

Ac-SDKP Side Effects

  • GI upset
  • hypotension at high exposure
  • unknown long-term safety

FGF2 Side Effects

  • local swelling
  • pain
  • fibroblast overgrowth/scarring
  • theoretical malignancy concern

Research Overview

Ac-SDKP

Ac-SDKP has literature in tissue remodeling, angiogenesis, and organ repair models. Its strongest evidence is pre-clinical, where it modulates inflammation and fibrosis during healing.

FGF2

FGF2 has extensive preclinical and clinical literature for skin ulcers, burns, and postsurgical repair, largely through angiogenic and mesenchymal-cell signaling. It remains one of the most studied repair factors for improving tissue perfusion and remodeling.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Ac-SDKP stacks with:

EGFFGF2

FGF2 stacks with:

EGFVEGF-A165
tetrapeptidetissue-remodelinganti-fibroticgrowth-factorangiogenesisrepair